These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29161793)

  • 1. Effect of Rifaximin on Hepatic Fibrosis in Bile Duct-ligated Rat Model.
    Shin SK; Kwon OS; Lee JJ; Park YH; Choi CS; Jeong SH; Choi DJ; Kim YS; Kim JH
    Korean J Gastroenterol; 2017 Nov; 70(5):239-246. PubMed ID: 29161793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibitory effect of angiotensin blockade on hepatic fibrosis in common bile duct-ligated rats].
    Park DH; Baik SK; Choi YH; Kim MY; Rhim DW; Kim JW; Kwon SO; Cho MY; Kim CH; Ahn SC
    Korean J Hepatol; 2007 Mar; 13(1):61-9. PubMed ID: 17380076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Yinchenhao decoction on self-regulation of renin-angiotensin system by targeting angiotensin converting enzyme 2 in bile duct-ligated rat liver.
    Wu L; Zhou PQ; Xie JW; Zhu R; Zhou SC; Wang G; Wu ZX; Hao S
    J Huazhong Univ Sci Technolog Med Sci; 2015 Aug; 35(4):519-524. PubMed ID: 26223920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model.
    Kim MY; Baik SK; Park DH; Jang YO; Suk KT; Yea CJ; Lee IY; Kim JW; Kim HS; Kwon SO; Cho MY; Ko SB; Chang SJ; Um SH; Han KH
    J Gastroenterol; 2008; 43(11):889-96. PubMed ID: 19012043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the nitric oxide donor molsidomine on the early stages of liver damage in rats with bile duct ligation: a biochemical and immunohistochemical approach.
    Oztürk H; Yağmur Y; Buyukbayram H; Dokucu AI; Gurel A
    Eur Surg Res; 2002; 34(4):285-90. PubMed ID: 12145554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated rats.
    Brusilovskaya K; Königshofer P; Lampach D; Szodl A; Supper P; Bauer D; Beer A; Stift J; Timelthaler G; Oberhuber G; Podesser BK; Seif M; Zinober K; Rohr-Udilova N; Trauner M; Reiberger T; Schwabl P
    United European Gastroenterol J; 2020 Dec; 8(10):1174-1185. PubMed ID: 32878579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course of collagen peak in bile duct-ligated rats.
    Tarcin O; Basaranoglu M; Tahan V; Tahan G; Sücüllü I; Yilmaz N; Sood G; Snyder N; Hilman G; Celikel C; Tözün N
    BMC Gastroenterol; 2011 Apr; 11():45. PubMed ID: 21527001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum hyaluronic acid level: correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model].
    Kim MY; Baik SK; Jang YO; Suk KT; Kim JW; Kim HS; Cho MY; Choi SJ; Um SH; Han KH
    Korean J Hepatol; 2008 Jun; 14(2):159-67. PubMed ID: 18617763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CGX, a multiple herbal drug, improves cholestatic liver fibrosis in a bile duct ligation-induced rat model.
    Kim HG; Han JM; Lee HW; Lee JS; Son SW; Choi MK; Lee DS; Wang JH; Son CG
    J Ethnopharmacol; 2013 Jan; 145(2):653-62. PubMed ID: 23228913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pomegranate peel extract prevents liver fibrosis in biliary-obstructed rats.
    Toklu HZ; Dumlu MU; Sehirli O; Ercan F; Gedik N; Gökmen V; Sener G
    J Pharm Pharmacol; 2007 Sep; 59(9):1287-95. PubMed ID: 17939210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aqueous extract of Artemisia iwayomogi Kitamura attenuates cholestatic liver fibrosis in a rat model of bile duct ligation.
    Han JM; Kim HG; Choi MK; Lee JS; Park HJ; Wang JH; Lee JS; Son SW; Hwang SY; Son CG
    Food Chem Toxicol; 2012 Oct; 50(10):3505-13. PubMed ID: 22824087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of the roots extract of Platycodon grandiflorum on bile duct ligation-induced hepatic fibrosis in rats.
    Lim JH; Kim TW; Song IB; Park SJ; Kim MS; Cho ES; Jung JY; Son HY; Kim JW; Yun HI
    Hum Exp Toxicol; 2013 Nov; 32(11):1197-205. PubMed ID: 23424213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of gastrodin on bile duct ligation-induced hepatic fibrosis in rats.
    Zhao S; Li N; Zhen Y; Ge M; Li Y; Yu B; He H; Shao RG
    Food Chem Toxicol; 2015 Dec; 86():202-7. PubMed ID: 26498411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline on bile duct ligation induced liver fibrosis in rats.
    Zhang L; Xu LM; Chen YW; Ni QW; Zhou M; Qu CY; Zhang Y
    World J Gastroenterol; 2012 Oct; 18(37):5283-8. PubMed ID: 23066324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lexipafant (BB-882), a platelet activating factor receptor antagonist, on liver damage due to bile duct ligation in rats.
    Oztürk H; Oztürk H; Dokucu AI; Otcu S
    Acta Gastroenterol Belg; 2006; 69(2):197-202. PubMed ID: 16929615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin ameliorates liver fibrosis induced by bile-duct ligation in rats.
    Tahan G; Akin H; Aydogan F; Ramadan SS; Yapicier O; Tarcin O; Uzun H; Tahan V; Zengin K
    Can J Surg; 2010 Oct; 53(5):313-8. PubMed ID: 20858375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats.
    Moal F; Veal N; Vuillemin E; Barrière E; Wang J; Fizanne L; Oberti F; Douay O; Gallois Y; Bonnefont-Rousselot D; Rousselet MC; Calès P
    World J Gastroenterol; 2006 Nov; 12(41):6639-45. PubMed ID: 17075977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AICAR-Induced AMPK Activation Inhibits the Noncanonical NF-κB Pathway to Attenuate Liver Injury and Fibrosis in BDL Rats.
    Zhu H; Chai Y; Dong D; Zhang N; Liu W; Ma T; Wu R; Lv Y; Hu L
    Can J Gastroenterol Hepatol; 2018; 2018():6181432. PubMed ID: 30662889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis.
    Song M; Song Z; Barve S; Zhang J; Chen T; Liu M; Arteel GE; Brewer GJ; McClain CJ
    J Pharmacol Exp Ther; 2008 May; 325(2):409-16. PubMed ID: 18299419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin K1 attenuates bile duct ligation-induced liver fibrosis in rats.
    Jiao K; Sun Q; Chen B; Li S; Lu J
    Scand J Gastroenterol; 2014 Jun; 49(6):715-21. PubMed ID: 24742111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.